0001035267-24-000265.txt : 20241113 0001035267-24-000265.hdr.sgml : 20241113 20241113162106 ACCESSION NUMBER: 0001035267-24-000265 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20241112 FILED AS OF DATE: 20241113 DATE AS OF CHANGE: 20241113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Curet Myriam CENTRAL INDEX KEY: 0001632901 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30713 FILM NUMBER: 241454621 BUSINESS ADDRESS: STREET 1: 1020 KIFER ROAD CITY: SUNNYVALE STATE: CA ZIP: 94086 BUSINESS PHONE: 408-523-7587 MAIL ADDRESS: STREET 1: 1020 KIFER ROAD CITY: SUNNYVALE STATE: CA ZIP: 94086 FORMER NAME: FORMER CONFORMED NAME: Myriam Curet DATE OF NAME CHANGE: 20150205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTUITIVE SURGICAL INC CENTRAL INDEX KEY: 0001035267 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 770416458 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1020 KIFER ROAD CITY: SUNNYVALE STATE: CA ZIP: 94086 BUSINESS PHONE: 4085232100 MAIL ADDRESS: STREET 1: 1020 KIFER ROAD CITY: SUNNYVALE STATE: CA ZIP: 94086 4 1 edgardoc.xml PRIMARY DOCUMENT X0508 4 2024-11-12 0 0001035267 INTUITIVE SURGICAL INC ISRG 0001632901 Curet Myriam 1020 KIFER ROAD SUNNYVALE CA 94086 0 1 0 0 EVP & Chief Medical Officer 1 Common Stock 2024-11-12 4 M 0 2257 177.9867 A 2555 D Common Stock 2024-11-12 4 S 0 2257 535.9569 D 298 D Common Stock 2024-11-12 4 M 0 5000 182.8333 A 5298 D Common Stock 2024-11-12 4 S 0 5000 535.9569 D 298 D Common Stock 2024-11-12 4 M 0 2199 229.39 A 2497 D Common Stock 2024-11-12 4 S 0 2199 535.9569 D 298 D Common Stock 2024-11-12 4 M 0 4010 208.9 A 4308 D Common Stock 2024-11-12 4 S 0 4010 535.9569 D 298 D Non-Qualified Stock Option (right to buy) 177.9867 2024-11-12 4 M 0 2257 0.0 D 2030-02-28 Common Stock 2257 0 D Non-Qualified Stock Option (right to buy) 182.8333 2024-11-12 4 M 0 5000 0.0 D 2029-02-15 Common Stock 5000 0 D Non-Qualified Stock Option (right to buy) 208.9 2024-11-12 4 M 0 4010 0.0 D 2029-08-28 Common Stock 4010 2005 D Non-Qualified Stock Option (right to buy) 229.39 2024-11-12 4 M 0 2199 0.0 D 2030-02-27 Common Stock 2199 2829 D The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 13, 2025. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $533.10 to $538.66 as follows: 4,510 shares sold at $533.10 to $534.07; 907 shares sold at $534.11 to $534.68; 200 shares sold at $535.34 to $536.28; 4,400 shares sold at $536.46 to $537.36; 3,437 shares sold at $537.49 to $538.36; and 12 shares sold at $538.66. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. By: Donna Spinola For: Curet, Myriam 2024-11-13 EX-24 2 poacuret2024.txt EDGAR SUPPORTING DOCUMENT POWER OF ATTORNEY Know all by these present that the undersigned hereby authorizes Donna Spinola, Stephanie Lim-Ignacio, Thanh Nhan Phan, and Cory Balliet of Intuitive Surgical, Inc. (the "Company") and Mark Roeder and John Williams of Latham & Watkins LLP, and each of them individually, to (i) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer or director of the Company, Forms 3, 4, and 5, and Notices of Proposed Sale of Securities Pursuant to Rule 144 ("Form 144"), in accordance with the requirements of Rule 144 under the Securities Act of 1933, as amended (the "Securities Act"), and other forms as may be required, and any amendments thereto, and cause such forms to be filed with the U.S. Securities and Exchange Commission (the "SEC") pursuant to Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and Rule 144 under the Securities Act, relating to the undersigned's ownership of and transactions in securities of the Company and (ii) execute for and on behalf of the undersigned in the undersigned's name, and submit to the SEC, a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain and/or regenerate codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Exchange Act, Rule 144 of the Securities Act or any rule or regulation of the SEC. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorneys-in-fact, or such attorneys- in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act or Rule 144 under the Securities Act. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 and Form 144 with respect to the undersigned's holdings of, and transactions in, securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this day of July 25, 2024. /s/ Myriam Curet MYRIAM CURET